Shah, Hely
Surujballi, Julian
Awan, Arif Ali
Hutton, Brian
Arnaout, Angel
Shorr, Risa
Vandermeer, Lisa
Alzahrani, Mashari Jemaan
Clemons, Mark http://orcid.org/0000-0002-0738-2713
Article History
Received: 24 August 2020
Accepted: 29 October 2020
First Online: 6 November 2020
Compliance with ethical standards
:
: Dr. Awan and Dr. Clemons report participating in the Novartis Canada Advisory Board on the use of Ribociclib. Dr. Hutton reports personal fees from Cornerstone Research, outside the submitted work. The remaining authors declare that they have no conflicts of interest.
: This scoping review did not involve human participation.
: This scoping review did not involve individual participation, and therefore, informed consent is not applicable.